about
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...
Read More
8.90
0.26
(3.01%)
1.2M
XNAS Volume
XNAS 30 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Vir biotech Inc is on 06 Aug 2026 for the purpose of Vir Biotechnology Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Vir biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..